{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:42:07Z","timestamp":1770748927098,"version":"3.50.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T00:00:00Z","timestamp":1291334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s12098-010-0295-7","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T05:27:48Z","timestamp":1291267668000},"page":"464-468","source":"Crossref","is-referenced-by-count":14,"title":["Latent Tuberculosis in Children: Diagnosis and Management"],"prefix":"10.1007","volume":"78","author":[{"given":"Meenu","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arushi Gahlot","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Anil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"295_CR1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM193810132191504","volume":"219","author":"JB Amberson","year":"1938","unstructured":"Amberson JB. The significance of latent forms of tuberculosis. N Engl J Med. 1938;219:572\u20136.","journal-title":"N Engl J Med"},{"key":"295_CR2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2004-0809","volume":"114","author":"Pediatric Tuberculosis Collaborative Group","year":"2004","unstructured":"Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics. 2004;114:1175\u2013201.","journal-title":"Pediatrics"},{"key":"295_CR3","first-page":"1","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","unstructured":"Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR Recomm Rep. 1994;43:1\u2013132.","journal-title":"MMWR Recomm Rep"},{"key":"295_CR4","first-page":"799","volume":"106","author":"S Chugh","year":"2008","unstructured":"Chugh S. Paediatric tuberculosis and DOTS strategy under RNTCP. J Indian Med Assoc. 2008;106:799\u2013802.","journal-title":"J Indian Med Assoc"},{"key":"295_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13312-010-0008-3","volume":"47","author":"Working Group on Tuberculosis, Indian Academy Of Pediatrics (IAP)","year":"2010","unstructured":"Working Group on Tuberculosis, Indian Academy Of Pediatrics (IAP). Consensus statement on childhood tuberculosis. Indian Pediatr. 2010;47:41\u201355.","journal-title":"Indian Pediatr"},{"key":"295_CR6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200511-1809SO","volume":"173","author":"BJ Marais","year":"2006","unstructured":"Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006;173:1078\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"295_CR7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.048033","volume":"61","author":"TG Connell","year":"2006","unstructured":"Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax. 2006;61:616\u201320.","journal-title":"Thorax"},{"key":"295_CR8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinf.2006.04.007","volume":"54","author":"S Dogra","year":"2007","unstructured":"Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007;54:267\u201376.","journal-title":"J Infect"},{"key":"295_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prrv.2007.04.002","volume":"8","author":"BJ Marais","year":"2007","unstructured":"Marais BJ, Pai M. New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev. 2007;8:124\u201333.","journal-title":"Paediatr Respir Rev"},{"key":"295_CR10","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC)","year":"2000","unstructured":"Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"295_CR11","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/S1526-0542(04)90025-5","volume":"5","author":"DA Enarson","year":"2004","unstructured":"Enarson DA. Use of the tuberculin skin test in children. Paediatr Respir Rev. 2004;5:S135\u20137.","journal-title":"Paediatr Respir Rev"},{"key":"295_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177\u201384.","journal-title":"Ann Intern Med"},{"key":"295_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.2007-3618","volume":"123","author":"J Lighter","year":"2009","unstructured":"Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics. 2009;123:30\u20137.","journal-title":"Pediatrics"},{"key":"295_CR14","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","volume":"364","author":"S Liebeschuetz","year":"2004","unstructured":"Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004;364:2196\u2013203.","journal-title":"Lancet"},{"key":"295_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/519266","volume":"45","author":"AK Detjen","year":"2007","unstructured":"Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis. 2007;45:322\u20138.","journal-title":"Clin Infect Dis"},{"key":"295_CR16","first-page":"31","volume":"138","author":"JP Zellweger","year":"2008","unstructured":"Zellweger JP. Latent tuberculosis: which test in which situation? Swiss Med Wkly. 2008;138:31\u20137.","journal-title":"Swiss Med Wkly"},{"key":"295_CR17","first-page":"406","volume":"29","author":"A Ciaschetti","year":"2007","unstructured":"Ciaschetti A, Franchi A, Richeldi L, et al. Screening of latent tuberculosis infection in health care workers by QuantiFERON-TB and tuberculin skin test. G Ital Med Lav Ergon. 2007;29:406\u20137.","journal-title":"G Ital Med Lav Ergon"},{"key":"295_CR18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-149-11-200812020-00248","volume":"149","author":"M Bakir","year":"2008","unstructured":"Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149:777\u201387.","journal-title":"Ann Intern Med"},{"key":"295_CR19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.08-2048","volume":"135","author":"R Diel","year":"2009","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest. 2009;135:1010\u20138.","journal-title":"Chest"},{"key":"295_CR20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3201\/eid1209.051606","volume":"12","author":"H Nakaoka","year":"2006","unstructured":"Nakaoka H, Lawson L, Squire SB, et al. Risk for tuberculosis among children. Emerg Infect Dis. 2006;12:1383\u20138.","journal-title":"Emerg Infect Dis"},{"key":"295_CR21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","volume":"361","author":"K Ewer","year":"2003","unstructured":"Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168\u201373.","journal-title":"Lancet"},{"key":"295_CR22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/382362","volume":"38","author":"PC Hill","year":"2004","unstructured":"Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis. 2004;38:966\u201373.","journal-title":"Clin Infect Dis"},{"key":"295_CR23","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1542\/peds.2005-2095","volume":"117","author":"PC Hill","year":"2006","unstructured":"Hill PC, Brookes RH, Adetifa IM, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics. 2006;117:1542\u20138.","journal-title":"Pediatrics"},{"key":"295_CR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1542\/peds.2008-0611","volume":"123","author":"MP Nicol","year":"2009","unstructured":"Nicol MP, Davies MA, Wood K, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics. 2009;123:38\u201343.","journal-title":"Pediatrics"},{"key":"295_CR25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/14737159.6.4.509","volume":"6","author":"M Pai","year":"2006","unstructured":"Pai M, O\u2019Brien R. Tuberculosis diagnostics trials: do they lack methodological rigor? Expert Rev Mol Diagn. 2006;6:509\u201314.","journal-title":"Expert Rev Mol Diagn"},{"key":"295_CR26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jinf.2006.06.011","volume":"54","author":"S Ranganathan","year":"2007","unstructured":"Ranganathan S, Connell T, Curtis N. Interferon-gamma release assays in children\u2013no better than tuberculin skin testing? J Infect. 2007;54:412\u20133.","journal-title":"J Infect"},{"key":"295_CR27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.00017807","volume":"29","author":"A Naseer","year":"2007","unstructured":"Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6\u00a0weeks following tuberculin skin testing. Eur Respir J. 2007;29:1282\u20133.","journal-title":"Eur Respir J"},{"key":"295_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/peds.2008-1722","volume":"123","author":"BM Bergamini","year":"2009","unstructured":"Bergamini BM, Losi M, Vaienti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009;123:419\u201324.","journal-title":"Pediatrics"},{"key":"295_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tube.2007.11.004","volume":"88","author":"SM Arend","year":"2008","unstructured":"Arend SM, Franken WP, Aggerbeck H, et al. Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis. 2008;88:249\u201361.","journal-title":"Tuberculosis"},{"key":"295_CR30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.2004-1525","volume":"114","author":"LJ Nelson","year":"2004","unstructured":"Nelson LJ, Jereb JA, Castro KG. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement. Pediatrics. 2004;114:1084\u20136.","journal-title":"Pediatrics"},{"key":"295_CR31","first-page":"1","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1\u201351.","journal-title":"MMWR Recomm Rep"},{"key":"295_CR32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM196110122651501","volume":"265","author":"FW Mount","year":"1961","unstructured":"Mount FW, Ferebee SH. Preventive effects of isoniazid in the treatment of primary tuberculosis in children. N Engl J Med. 1961;265:713\u201321.","journal-title":"N Engl J Med"},{"key":"295_CR33","first-page":"773","volume":"100","author":"GW Comstock","year":"1969","unstructured":"Comstock GW, Hammes LM, Pio A. Isoniazid prophylaxis in Alaskan Boarding schools. A comparison of two doses. Am Rev Respir Dis. 1969;100:773\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"295_CR34","first-page":"28","volume":"26","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28\u2013106.","journal-title":"Bibl Tuberc"},{"key":"295_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1542\/peds.64.4.499","volume":"64","author":"MT Stein","year":"1979","unstructured":"Stein MT, Liang D. Clinical hepatotoxicity of isoniazid in children. Pediatrics. 1979;64:499\u2013505.","journal-title":"Pediatrics"},{"key":"295_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.72.4.491","volume":"72","author":"RJ O\u2019Brien","year":"1983","unstructured":"O\u2019Brien RJ, Long MW, Cross FS, Lyle MA, Snider Jr DE. Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics. 1983;72:491\u20139.","journal-title":"Pediatrics"},{"key":"295_CR37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1542\/peds.2008-0433","volume":"123","author":"SM Finnell","year":"2009","unstructured":"Finnell SM, Christenson JC, Downs SM. Latent tuberculosis infection in children: a call for revised treatment guidelines. Pediatrics. 2009;123:816\u201322.","journal-title":"Pediatrics"},{"key":"295_CR38","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","volume":"155","author":"ME Villarino","year":"1997","unstructured":"Villarino ME, Ridzon R, Weismuller PC, et al. Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Respir Crit Care Med. 1997;155:1735\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"295_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.78.2.169","volume":"78","author":"LP Ormerod","year":"1998","unstructured":"Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child. 1998;78:169\u201371.","journal-title":"Arch Dis Child"},{"key":"295_CR40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00006454-198909000-00019","volume":"8","author":"MM Nakajo","year":"1989","unstructured":"Nakajo MM, Rao M, Steiner P. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatr Infect Dis J. 1989;8:649\u201350.","journal-title":"Pediatr Infect Dis J"},{"key":"295_CR41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","volume":"53","author":"Joint Tuberculosis Committee of the British Thoracic Society","year":"1998","unstructured":"Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax. 1998;53:536\u201348.","journal-title":"Thorax"},{"key":"295_CR42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","volume":"45","author":"NP Spyridis","year":"2007","unstructured":"Spyridis NP, Spyridis PG, Gelesme A, et al. The effectiveness of a 9\u00a0month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis. 2007;45:715\u201322.","journal-title":"Clin Infect Dis"},{"key":"295_CR43","first-page":"761","volume":"48","author":"K Magdorf","year":"1994","unstructured":"Magdorf K, Arizzi-Rusche AF, Geiter LJ, O\u2019Brien RJ, Wahn U. Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood\u2013a pilot project. Pneumologie. 1994;48:761\u20134.","journal-title":"Pneumologie"},{"key":"295_CR44","unstructured":"Prevention CDC. Update: Adverse event data and Revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2014United States, 2003."},{"key":"295_CR45","first-page":"1093","volume":"34","author":"Indian Academy of Pediatrics","year":"1997","unstructured":"Indian Academy of Pediatrics. Treatment of childhood tuberculosis: Consensus Statement of IAP Working Group. Indian Pediatr. 1997;34:1093\u20136.","journal-title":"Indian Pediatr"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-010-0295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-010-0295-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-010-0295-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T10:18:40Z","timestamp":1685873920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-010-0295-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1007\/s12098-010-0295-7","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}